Glioblastome Multiforme
1 clinical trials · Condition
◉ Watch Glioblastome Multiforme
| Record | Firm | Date |
|---|---|---|
| A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies (NCT04172597) | Spectrum Pharmaceuticals, Inc | 2019-12-23 |
Track Glioblastome Multiforme automatically
Every clearance here is in the API, with alerts when new ones post.